May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Prevention of Corneal Neovascularization: Evaluation of Various Commercially Available Compounds in an Experimental Rat Model
Author Affiliations & Notes
  • M. Riazi Esfahani
    Ophthalmology, Tulane University Health Sciences Center, New Orleans, LA
    Ophthalmology, Tehran University Eye Research Center, Tehran, Iran (Islamic Republic of)
  • G.A. Peyman
    Ophthalmology, Tulane University Health Sciences Center, New Orleans, LA
  • E. Aydin
    Ophthalmology, Gaziosmanpasa University, Tokat, Turkey
  • A.A. Kazi
    Ophthalmology, Tulane University Health Sciences Center, New Orleans, LA
    Ophthalmology, Isra University, Hyderabad, Pakistan
  • D. Sanders
    Ophthalmology, University of Illinois College of Medicine, Chicago, IL
  • Footnotes
    Commercial Relationships  M. Riazi Esfahani, None; G.A. Peyman, None; E. Aydin, None; A.A. Kazi, None; D. Sanders, Regenera Limited I, C.
  • Footnotes
    Support  Regenera Limited
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4480. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Riazi Esfahani, G.A. Peyman, E. Aydin, A.A. Kazi, D. Sanders; Prevention of Corneal Neovascularization: Evaluation of Various Commercially Available Compounds in an Experimental Rat Model . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4480.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the effect of topically administered agents such as doxycycline, triamcinolone, low molecular weight heparin (LMWH), ascomycin, and flurbiprofen on experimental corneal neovascularization in rats. Methods: Chemical cauterization of cornea in 40 eyes of 40 rats was performed by using silver nitrate/potassium nitrate sticks. The animals were anesthetized and were treated in accordance with the ARVO statement for the use of animals in ophthalmic and visual research. Topical instillation of doxycycline, triamcinolone, LMWH, ascomycin, flurbiprofen, and normal saline was continued for 7 days. Percent area of cornea covered by neovascularization and also covered by scar in each group was calculated separately by use of computer software on digital photographs. Means of different groups were compared to find any significant (p< 0.05) difference between groups. Results: The means of percent area of corneal neovascularization were: in doxycycline, 35.5%; in triamcinolone, 13.2%; in LMWH, 66.6%; in ascomycin, 55.9%; in flurbiprofen 50.5%; and in the control group, 74.9%. The means of percent area of neovascularization in triamcinolone and doxycycline groups were different from the control group (p< 0.05). There was no significant difference in the percent area of neovascularization between the LMWH, ascomycin, and flurbiprofen groups when compared to the control. There was no significant difference in percent area of corneal scar between the different groups. Conclusions: Topical instillation of triamcinolone and doxycycline seems to prevent corneal neovascularization induced by chemical cauterization of cornea in rats. Although the effect of LMWH, ascomycin, and flurbiprofen is not significant, there seems to be a trend. Because the mechanisms of action of these agents are not identical, performing other studies using combinations of these drugs seems to be reasonable.

Keywords: neovascularization • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×